A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250
Status:
Terminated
Trial end date:
2020-08-10
Target enrollment:
Participant gender:
Summary
A trial to assess the efficacy, safety, tolerability and effect of a drug (code name TRV250)
given as an injection to subjects who have received an injection of a drug called glyceryl
trinitrate (GTN) which is clinically known to induce an immediate headache of short duration
(under 30 minutes), known as the "GTN immediate headache"